Ignite Planners LLC Sells 91 Shares of Danaher Corporation $DHR

Ignite Planners LLC reduced its holdings in shares of Danaher Corporation (NYSE:DHR) by 6.9% in the second quarter, according to its most recent filing with the SEC. The fund owned 1,237 shares of the conglomerate’s stock after selling 91 shares during the period. Ignite Planners LLC’s holdings in Danaher were worth $235,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. GHP Investment Advisors Inc. lifted its stake in shares of Danaher by 396.0% during the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate’s stock worth $25,000 after acquiring an additional 99 shares during the last quarter. Sierra Ocean LLC raised its position in Danaher by 116.9% during the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate’s stock valued at $29,000 after purchasing an additional 76 shares in the last quarter. Red Tortoise LLC raised its position in Danaher by 175.0% during the 2nd quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock valued at $30,000 after purchasing an additional 98 shares in the last quarter. Smallwood Wealth Investment Management LLC bought a new stake in Danaher during the 1st quarter valued at $31,000. Finally, Dunhill Financial LLC raised its position in Danaher by 68.4% during the 1st quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate’s stock valued at $34,000 after purchasing an additional 67 shares in the last quarter. 79.05% of the stock is owned by institutional investors.

Insiders Place Their Bets

In related news, Director Teri List sold 2,778 shares of the business’s stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the transaction, the director directly owned 20,751 shares in the company, valued at $4,379,706.06. The trade was a 11.81% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 11.10% of the stock is currently owned by company insiders.

Danaher Stock Down 1.7%

Shares of DHR stock opened at $205.13 on Thursday. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $279.41. The stock’s fifty day moving average price is $200.41 and its 200 day moving average price is $197.38. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22. The company has a market cap of $146.88 billion, a price-to-earnings ratio of 43.64, a price-to-earnings-growth ratio of 2.97 and a beta of 0.77.

Danaher (NYSE:DHR) last announced its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, topping the consensus estimate of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The firm had revenue of $5.94 billion for the quarter, compared to the consensus estimate of $5.83 billion. During the same period in the previous year, the business earned $1.72 EPS. The firm’s revenue for the quarter was up 3.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, research analysts expect that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be paid a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.6%. The ex-dividend date is Friday, September 26th. Danaher’s payout ratio is 27.23%.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on DHR. Redburn Partners set a $220.00 target price on Danaher in a research report on Wednesday. Wall Street Zen raised Danaher from a “hold” rating to a “buy” rating in a research report on Friday, June 27th. Scotiabank raised Danaher from a “sector perform” rating to a “sector outperform” rating and set a $275.00 target price for the company in a research report on Friday, July 11th. Bank of America decreased their target price on Danaher from $230.00 to $220.00 and set a “buy” rating for the company in a research report on Monday, September 22nd. Finally, Robert W. Baird lifted their target price on Danaher from $225.00 to $226.00 and gave the company an “outperform” rating in a research report on Friday, July 18th. Seventeen investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $244.60.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.